NCT06050057 Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy
| NCT ID | NCT06050057 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Olomouc |
| Condition | Adrenal Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-09-03 |
| Primary Completion | 2024-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-09-03 with a primary completion date of 2024-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this multicenter, observational, analytic, randomized clinical trial is to analyze the laparoscopic and robot-assisted method in the surgical treatment of patients with adrenal diseases. The main question it aims to answer are: 1. to find the superiority of one the the surgical method mentioned above 2. to compare the quality of life in patients with adrenal mass before surgery and after laparoscopic or robotic-assisted adrenalectomy.
Eligibility Criteria
Inclusion Criteria: * Indicated adrenalectomy based on endocrinological and imaging examination. * Written consent to participate in the study. Exclusion Criteria: * Simultaneous bilateral adrenalectomy. * Adrenal expansion \> 12 cm. * Suspected malignant adrenal tumor with infiltrative growth or tumor venous thrombus according to imaging examination.
Contact & Investigator
MUDr. Igor Hartmann Ph.D.
STUDY CHAIR
Dpt. of Urology, University hospital Olomouc
Frequently Asked Questions
Who can join the NCT06050057 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Adrenal Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06050057 currently recruiting?
Yes, NCT06050057 is actively recruiting participants. Contact the research team at Igor.Hartmann@fnol.cz for enrollment information.
Where is the NCT06050057 trial being conducted?
This trial is being conducted at Olomouc, Czechia.
Who is sponsoring the NCT06050057 clinical trial?
NCT06050057 is sponsored by University Hospital Olomouc. The principal investigator is MUDr. Igor Hartmann Ph.D. at Dpt. of Urology, University hospital Olomouc. The trial plans to enroll 100 participants.